Evidence map›Paper›PMID 28709984›Full record

ArticleActa biomaterialia2017

Micrometer scale guidance of mesenchymal stem cells to form structurally oriented large-scale tissue engineered cartilage.

Chih-Ling Chou, Alexander L Rivera, Valencia Williams, Jean F Welter, Joseph M Mansour, Judith A Drazba, Takao Sakai, Harihara Baskaran

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Apparatus and Method for Rapid Detection of Acoustic Anisotropy in Cartilage.Journal of medical and biological engineering · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chih-Ling ChouDepartment of Chemical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Alexander L RiveraDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Valencia WilliamsDepartment of Chemical Engineering, Case Western Reserve University, Cleveland, OH, United States.
Jean F WelterSkeletal Research Center, Department of Biology, Case Western Reserve University, Cleveland, OH, United States; Center for Multimodal Evaluation of Engineered Cartilage, Case Western Reserve University, Cleveland, OH, United States.
Joseph M MansourDepartment of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, OH, United States; Center for Multimodal Evaluation of Engineered Cartilage, Case Western Reserve University, Cleveland, OH, United States.
Judith A DrazbaLerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Takao SakaiDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Harihara BaskaranDepartment of Chemical Engineering, Case Western Reserve University, Cleveland, OH, United States; Center for Multimodal Evaluation of Engineered Cartilage, Case Western Reserve University, Cleveland, OH, United States.
Case Western Reserve University · USCleveland Clinic Lerner College of Medicine · USUniversity of Liverpool · GB

Funding

TR&D-4: Growing Tissue in the Scalable, Modular, Automated, and Closed (SMAC) FoundryP41EB021911 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI JEAN F WELTER · 2016 to 2026
$13.9M
Total Joint ResurfacingP01AR053622 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI MANSOUR, JOSEPH M · 2008 to 2012
$6.0M
NIAMS NIH HHS P01 AR053622NIBIB NIH HHS P41 EB021911
6 · The paper itself

Abstract

Current clinical methods to treat articular cartilage lesions provide temporary relief of the symptoms but fail to permanently restore the damaged tissue. Tissue engineering, using mesenchymal stem cells (MSCs) combined with scaffolds and bioactive factors, is viewed as a promising method for repairing cartilage injuries. However, current tissue engineered constructs display inferior mechanical properties compared to native articular cartilage, which could be attributed to the lack of structural organization of the extracellular matrix (ECM) of these engineered constructs in comparison to the highly oriented structure of articular cartilage ECM. We previously showed that we can guide MSCs undergoing chondrogenesis to align using microscale guidance channels on the surface of a two-dimensional (2-D) collagen scaffold, which resulted in the deposition of aligned ECM within the channels and enhanced mechanical properties of the constructs. In this study, we developed a technique to roll 2-D collagen scaffolds containing MSCs within guidance channels in order to produce a large-scale, three-dimensional (3-D) tissue engineered cartilage constructs with enhanced mechanical properties compared to current constructs. After rolling the MSC-scaffold constructs into a 3-D cylindrical structure, the constructs were cultured for 21days under chondrogenic culture conditions. The microstructure architecture and mechanical properties of the constructs were evaluated using imaging and compressive testing. Histology and immunohistochemistry of the constructs showed extensive glycosaminoglycan (GAG) and collagen type II deposition. Second harmonic generation imaging and Picrosirius red staining indicated alignment of neo-collagen fibers within the guidance channels of the constructs. Mechanical testing indicated that constructs containing the guidance channels displayed enhanced compressive properties compared to control constructs without these channels. In conclusion, using a novel roll-up method, we have developed large scale MSC based tissue-engineered cartilage that shows microscale structural organization and enhanced compressive properties compared to current tissue engineered constructs. STATEMENT OF SIGNIFICANCE: Tissue engineered cartilage constructs made with human mesenchymal stem cells (hMSCs), scaffolds and bioactive factors are a promising solution to treat cartilage defects. A major disadvantage of these constructs is their inferior mechanical properties compared to the native tissue, which is likely due to the lack of structural organization of the extracellular matrix of the engineered constructs. In this study, we developed three-dimensional (3-D) cartilage constructs from rectangular scaffold sheets containing hMSCs in micro-guidance channels and characterized their mechanical properties and metabolic requirements. The work led to a novel roll-up method to embed 2-D microscale structures in 3-D constructs. Further, micro-guidance channels incorporated within the 3-D cartilage constructs led to the production of aligned cell-produced matrix and enhanced mechanical function.

Indexed as

ChondrogenesisAnimalsCartilageCattleCells, CulturedCollagenHumansMesenchymal Stem CellsTissue EngineeringTissue ScaffoldsCollagenChondrogenesisContact guidanceLarge-scale constructsOsteoarthritisTissue engineering

Identifiers

PMID28709984
PMCPMC5581212
OpenAlexW2734516029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.